Pascal and Francis Bibliographic Databases

Help

Export

Selection :

Permanent link
http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=1636818

Retinoic acid and interferon α act synergistically as antiangiogenic and antitumor agents against human head and neck squamous cell carcinoma

Author
LINGEN, M. W1 ; POLVERINI, P. J2 ; BOUCK, N. P3
[1] Department of Pathology, the R. H. Lurie Cancer Center, Northwestern University Medical and Dental Schools, Chicago, Illinois 60611, United States
[2] The Laboratory of Molecular Pathology, The University of Michigan School of Dentistry Arbor, Michigan 48109, United States
[3] Department of Microbiology-Immunology, the R. H. Lurie Cancer Center, Northwestern University Medical and Dental Schools, Chicago, Illinois 60611, United States
Source

Cancer research (Baltimore). 1998, Vol 58, Num 23, pp 5551-5558 ; ref : 55 ref

CODEN
CNREA8
ISSN
0008-5472
Scientific domain
Medical oncology; Pharmacology drugs
Publisher
American Association for Cancer Research, Philadelphia, PA
Publication country
United States
Document type
Article
Language
English
Keyword (fr)
Angiogenèse Animal Anticancéreux Association médicamenteuse Carcinome épidermoïde Cellule tumorale Efficacité traitement Homme Immunochimiothérapie In vitro In vivo Interféron alpha Lignée cellulaire établie Néovascularisation Rétinoïque acide Souris Synergie Toxicité Traitement associé Tête cou Cytokine Mammalia ORL pathologie Rodentia Tumeur maligne Vertebrata
Keyword (en)
Angiogenesis Animal Antineoplastic agent Drug combination Squamous cell carcinoma Tumor cell Treatment efficiency Human Immunochemotherapy In vitro In vivo Alpha interferon Established cell line Neovascularization Retinoic acid Mouse Synergism Toxicity Combined treatment Head and neck Cytokine Mammalia ENT disease Rodentia Malignant tumor Vertebrata
Keyword (es)
Angiogénesis Animal Anticanceroso Asociación medicamentosa Carcinoma epidermoide Célula tumoral Eficacia tratamiento Hombre Inmunoquimioterapia In vitro In vivo Interferón alfa Línea celular establecida Neovascularización Retinoico ácido Ratón Sinergia Toxicidad Tratamiento asociado Cabeza cuello Citoquina Mammalia ORL patología Rodentia Tumor maligno Vertebrata
Classification
Pascal
002 Biological and medical sciences / 002B Medical sciences / 002B02 Pharmacology. Drug treatments / 002B02R Antineoplastic agents / 002B02R04 Combined treatments (chemotherapy of immunotherapy associated with an other treatment)

Discipline
Pharmacological treatments
Origin
Inist-CNRS
Database
PASCAL
INIST identifier
1636818

Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS

Searching the Web